My Cart [ 0 ]
Home > Antibodies > Research-Grade Biosimilars > Sotatercept Biosimilar, Anti-EDF Fusion Protein

Sotatercept Biosimilar, Anti-EDF Fusion Protein

EDF; Erythroid differentiation protein; Activin beta-A chain; INHBA; Inhibin beta A chain

Catalog No. Product Name Size List Price (US$) Quantity
C113P Sotatercept Biosimilar, Anti-EDF Fusion Protein 1 mg 250.00
C113P Sotatercept Biosimilar, Anti-EDF Fusion Protein 5 mg 750.00
C113P Sotatercept Biosimilar, Anti-EDF Fusion Protein 20 mg 2000.00
Description

C113P: Sotatercept Biosimilar, Anti-EDF Fusion Protein

Isotype: Fusion - [ACVR2A (activin A receptor type 2A, ActR-II, ActRIIA)]2 - IGHG1 Fc (Fragment constant).
Source: The anti-EDF fusion protein sotatercept biosimilar was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade sotatercept biosimilar specifically binds to the EDF protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by sotatercept.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The research grade sotatercept biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

Related Links

See our Privacy Policy